4.3 Review

Systematic review of national and international guidelines on attention-deficit hyperactivity disorder

期刊

JOURNAL OF PSYCHOPHARMACOLOGY
卷 26, 期 6, 页码 753-765

出版社

SAGE PUBLICATIONS LTD
DOI: 10.1177/0269881111412095

关键词

Attention-deficit hyperactivity disorder; diagnosis; guidelines; therapeutics

资金

  1. Janssen-Cilag
  2. Eli Lilly
  3. Shire
  4. Purdue

向作者/读者索取更多资源

During the last few years several clinical guidelines on attention-deficit hyperactivity disorder (ADHD) have been published by national and international medical societies. To systematically review and compare recommendations of selected ADHD guidelines, we performed a systematic search in online guideline databases and PubMed in order to retrieve guideline texts. Guidelines meeting inclusion criteria were reviewed and recommendations on assessment and treatment extracted. The AGREE instrument was used to assess methodological quality. Of the 26 guidelines identified, 13 were selected for further analysis: 11 guidelines deal with ADHD in childhood and adolescence and 5 guidelines cover transitional patients and/or ADHD in adults. The methodological quality of ADHD guidelines is moderate to good. They reflect similarities and differences of healthcare systems. Diagnosis throughout the lifespan is based on a detailed clinical history. There is greater agreement on evidence-based pharmacological treatment than on psychosocial interventions, reflecting the strength of evidence.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据